which glp 1 agonists are approved for weight loss GLP-1s Loss: What You Need to Know List of approved and pending

Jager J, Gremeaux T, Cormont M, Le Marchand-Brustel Y, Tanti JF

The BMJ

Weight Loss Drugs in Development Doctors are studying new treatment strategies to help people lose weight and to stay at a healthy weight

This impairment alone could contribute to the pathogenesis of diabetes

Key findings at the highest dose (12mg weekly): Up to 24% mean body weight reduction over 48 weeks Significant reductions in fasting glucose and insulin resistance markers Meaningful reductions in liver fat content, relevant for participants with metabolic-associated fatty liver disease Once-weekly subcutaneous dosing was generally well-tolerated For context, semaglutide at its approved dose achieves approximately 1517% body weight reduction over 68 weeks

Accessed August 2024 at Hurtado MD, Tama E, Fansa S, et al